British journal of haematology, 2020-08, Vol.190 (4), p.e242-e245
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Secondary plasma cell leukaemia treated with single agent venetoclax
- Ist Teil von
- British journal of haematology, 2020-08, Vol.190 (4), p.e242-e245
- Ort / Verlag
- England: Blackwell Publishing Ltd
- Erscheinungsjahr
- 2020
- Quelle
- Wiley Online Library - AutoHoldings Journals
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0007-1048eISSN: 1365-2141DOI: 10.1111/bjh.16858Titel-ID: cdi_proquest_journals_2434419602
- Format
- –
- Schlagworte
- Aged, Antibodies, Monoclonal - therapeutic use, Antineoplastic Agents - pharmacology, Antineoplastic Agents - therapeutic use, Antineoplastic Agents, Immunological - therapeutic use, Antineoplastic Combined Chemotherapy Protocols - therapeutic use, BCL‐2, Bridged Bicyclo Compounds, Heterocyclic - pharmacology, Bridged Bicyclo Compounds, Heterocyclic - therapeutic use, Chromosomes, Human, Pair 11 - genetics, Chromosomes, Human, Pair 11 - ultrastructure, Chromosomes, Human, Pair 14 - genetics, Chromosomes, Human, Pair 14 - ultrastructure, Combined Modality Therapy, Drug Resistance, Neoplasm, Female, Hematology, Humans, leukaemia cytogenetics, leukaemia therapy, Leukemia, Leukemia, Plasma Cell - blood, Leukemia, Plasma Cell - drug therapy, Leukemia, Plasma Cell - genetics, Leukemia, Plasma Cell - therapy, multiple myeloma, Multiple Myeloma - drug therapy, myeloma theraphy, Neoplasm Proteins - antagonists & inhibitors, Neoplasms, Second Primary - drug therapy, Plasma Cells, Plasmapheresis, Progression-Free Survival, Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors, Sulfonamides - pharmacology, Sulfonamides - therapeutic use, Translocation, Genetic